Stein, E., Sampietro, T., Santos, R., Harada-Shiba, M., Bruckert, E., Blom, D., Hovingh, G., Couture, P., Blaha, V., Farnier, M., Descamps, O., Soran, H., Kasichayanula, S., Gibbs, J., Kurtz, C., Tang, L., Honarpour, N., Wasserman, S., & Raal, F. (2016). long-term treatment with evolocumab homozygous familial hypercholesterolemia patients: Results from the trial assessing long-term use of PCSK9 inhibition in subjects with genetic LDL disorders (Taussig). Atherosclerosis, 252, e44–. http://access.bl.uk/ark:/81055/vdc_100039989489.0x00004c